Research in the CGP program focuses on defining essential molecular and biological mechanisms underlying tumor pathogenesis and successful therapy.

The primary goal of this basic science program is to discover, characterize, and validate new tumor alterations (genetic, molecular, and cellular pathways) to fuel translational cancer research that will lead to improved cancer patient outcomes.

Program focuses on:

  • Determining mechanisms of tumor evolution and metastasis
  • Characterizing tumor immunology and microenvironment
  • Defining mechanisms of therapy response and resistance in tumors

Program Leadership

Rebecca D. Dodd, PhD

Rebecca D. Dodd, PhD

Program Co-Leader

Associate Professor, Internal Medicine-Hematology, Oncology, and Blood and Marrow Transplantation

Dawn E. Quelle, PhD

Dawn E. Quelle, PhD

Program Co-Leader

Professor, Neuroscience and Pharmacology

Erin Talbert, PhD

Erin E. Talbert, PhD

Assistant Program Leader

Assistant Professor, Health and Human Physiology